<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>Oppenheimer Global Multi-asset Growth Fu — News on 6ix</title>
    <link>https://6ix.com/company/oppenheimer-global-multi-asset-growth-fu</link>
    <description>Latest news and press releases for Oppenheimer Global Multi-asset Growth Fu on 6ix.</description>
    <language>en-us</language>
    <lastBuildDate>Tue, 21 Apr 2026 04:00:00 GMT</lastBuildDate>
    <generator>6ix RSS</generator>
    <atom:link href="https://6ix.com/rss/company/oppenheimer-global-multi-asset-growth-fu" rel="self" type="application/rss+xml" />
    <item>
      <title>Autolus Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)</title>
      <link>https://6ix.com/company/oppenheimer-global-multi-asset-growth-fu/news/autolus-therapeutics-announces-inducement-grants-under-nasdaq-listing-rule-5635c4-1</link>
      <guid isPermaLink="true">https://6ix.com/company/oppenheimer-global-multi-asset-growth-fu/news/autolus-therapeutics-announces-inducement-grants-under-nasdaq-listing-rule-5635c4-1</guid>
      <pubDate>Tue, 21 Apr 2026 04:00:00 GMT</pubDate>
      <description>LONDON and GAITHERSBURG, Md., April 21, 2026 (GLOBE NEWSWIRE) -- Autolus Therapeutics plc (Nasdaq: AUTL), a commercial-stage biopharmaceutical company</description>
    </item>
  </channel>
</rss>